Sign in to follow this  
Followers 0
Joelf

Outcome of a glucocorticoid (GC) discontinuation regimen in patients with inactive systemic sclerosis.

1 post in this topic

Outcome of a glucocorticoid (GC) discontinuation regimen in patients with inactive systemic sclerosis.

 

Disability as assessed by Health Assessment Questionnaire Disability Index (HAQ–DI) was the leading factor hindering GC discontinuation, as a low HAQ–DI score can identify candidates for GC discontinuation. PubMed, Clin Rheumatol, 2016 Aug;35(8):1985-91. (Also see Glucocorticoids, Steroids (Prednisone) Warnings for Scleroderma)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde

ISN Assistant Webmaster

SD World Webmaster

ISN Sclero Forums Manager

ISN News Manager

ISN Hotline Support Specialist

International Scleroderma Network (ISN)

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!


Register a new account

Sign in

Already have an account? Sign in here.


Sign In Now
Sign in to follow this  
Followers 0